VALIANT LABORATORIES
|
The Current P/S Ratio of VALIANT LABORATORIES is 2.69.
| Share Price | ₹80.0 | Nov 06,2025 |
| Market Cap | ₹434.4 Cr | |
| Sales-TTM | ₹161.3 Cr | TTM-Consolidated Results |
| Price/Sales | 2.69x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VALIANT LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹434.4 Cr] as on Nov 06,2025
(/) Sales [ ₹161.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.69x ]
Thus, for VALIANT LABORATORIES , the investors are currently willing to pay '2.69 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VALIANT LABORATORIES !
The chart below summarizes the trend in P/S Ratio of VALIANT LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of VALIANT LABORATORIES
PS Ratio Performance Analysis for VALIANT LABORATORIES
- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 1.99x.
- VALIANT LABORATORIES 's operated at median p/e ratio of 2.5x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2024 at 3.47x.
- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does VALIANT LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VALIANT LABORATORIES | 161.3 | 2.69 | 434.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.36 | 404,468.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 18.94 | 182,810.0 |
| CIPLA LTD | 28,349.6 | 4.27 | 121,170.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.16 | 120,300.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.93 | 100,575.0 |
| MANKIND PHARMA LTD | 13,576.9 | 7.02 | 95,320.4 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.85 | 94,208.7 |
| LUPIN LTD | 23,375.9 | 3.82 | 89,345.0 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.04 | 66,243.3 |
| ABBOTT INDIA LTD | 6,714.4 | 9.33 | 62,639.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VALIANT LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.04x |
| Max industry PS | 18.94x |
| Median industry PS | 4.27x |
| Average industry PS | 6.58x |
You may also like the below Video Courses